一项2025年6月的调查显示,80%的美国人支持专利改革,以降低药品价格,其中多数以高成本和过高利润为借口。 A June 2025 survey shows 80% of Americans support patent reform to lower drug prices, with most citing high costs and excessive profits.

2025年6月对726名美国人的调查发现,80%支持专利改革以降低处方药价格,这反映了强烈的两党协议。 A June 2025 survey of 726 Americans found 80% support patent reform to lower prescription drug prices, reflecting strong bipartisan agreement. 其中三分之一的药物使用者因成本而跳过或推迟开处方, 去年有31%的药方无法至少服完一次药。 One in three medication users skipped or delayed prescriptions due to cost, and 31% couldn’t fill at least one in the past year. 近70%认为医疗体系需要重大改革, 多数人认为美国药品价格太高, 制药公司利润过高。 Nearly 70% believe the healthcare system needs major reform, with most saying U.S. drug prices are too high and pharmaceutical companies profit excessively. 虽然政府价格管制得到的支持较少,但专利改革——被视为一种以市场为基础的解决办法,以加速非专利药物的获得——得到明显多数的赞同,为提高可负担性提供了一条政治上可行的道路。 While government price controls have less support, patent reform—seen as a market-based solution to accelerate generic drug access—is favored by a clear majority, offering a politically viable path to improving affordability.